Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors

Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors

The invention encompasses compounds of formula I as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Gentles, Robert G, Hewawasam, Piyasena, Ding, Min, Bergstrom, Carl P, Martin, Scott W, Yeung, Kap-Sun, Hudyma, Thomas W, Zheng, Xiaofan, Bender, John A, Kadow, John F
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The invention encompasses compounds of formula I as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.